IDiyas

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Richard Eric Olson

USPTO Granted Patents = 108 

 

Average Co-Inventor Count = 3.1

ph-index = 16

Forward Citations = 963(Granted Patents)


Inventors with similar research interests:


Location History:

  • Wilmington, DE (US) (1988 - 2010)
  • Orange, CT (US) (2010 - 2022)
  • Wallingford, CT (US) (2021 - 2022)
  • Cambridge, MA (US) (2020 - 2024)

Company Filing History:

goldMedal43 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal27 out of 234 
 
Bristol-myers Squibb Pharma Company
 patents
bronzeMedal9 out of 16,338 
 
E.i. Dupont De Nemours and Company
 patents
4. 6 out of 206 
 
The Dupont Merck Pharmaceutical Company
 patents
5. 6 out of 97 
 
Albany Molecular Research, Inc.
 patents
6. 5 out of 106 
 
Dupont Pharmaceuticals Company
 patents
7. 4 out of 46 
 
Roche Innovation Center Copenhagen A/s
 patents
8. 3 out of 4,770 
 
Merck + Co., Inc.
 patents
9. 3 out of 10 
 
Bristol-myers Squibb Pharma Corporation
 patents
10. 3 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents
11. 2 out of 15 
 
Dupont Pharmaceuticals, Inc.
 patents
12. 2 out of 168 
 
F. Hoffmann-la Roche Ag
 patents
13. 2 out of 1,186 
 
The Scripps Research Institute
 patents
14. 1 out of 1 
 
E. I. Du Pont De Nemours and Cmopany
 patent
15. 1 out of 41 
 
Bristol Meyers Squibb Company
 patents
16. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...
Loading Chart...
108 patents (USPTO):
1. 12454531 - Substituted piperazine derivatives useful as T cell activators (2025-10-28),
2. 12241065 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2025-03-04),
3. 12180478 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2024-12-31),
4. 12163131 - Oligonucleotides for modulating Tau expression (2024-12-10),
5. 12077558 - Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds (2024-09-03),
6. 11964973 - Substituted bicyclic compounds useful as T cell activators (2024-04-23),
7. 11866430 - Naphthyridinone compounds useful as T cell activators (2024-01-09),
8. 11761951 - Methods of selecting therapeutic molecules (2023-09-19),
9. 11753640 - Oligonucleotides for modulating Tau expression (2023-09-12),
10. 11713316 - Substituted naphthyridinone compounds useful as T cell activators (2023-08-01),
11. 11613554 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds (2023-03-28),
12. 11584747 - Substituted pyridopyrimidinonyl compounds useful as T cell activators (2023-02-21),
13. 11447775 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2022-09-20),
14. 11359197 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2022-06-14),
15. 11279929 - Oligonucleotides for modulating Tau expression (2022-03-22),

Title: The Innovative Journey of Richard Eric Olson

Introduction: Richard Eric Olson, a pioneering inventor based in Wilmington, DE (US), has made significant contributions to the field of technology through his inventive spirit and dedication to innovation.

Latest Patents: Richard Eric Olson holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a background in engineering and a passion for problem-solving, Richard Eric Olson has successfully developed groundbreaking solutions that have improved efficiency and functionality across different industries. His innovative mindset has led to the creation of cutting-edge technologies that have garnered recognition worldwide.

Collaborations: Throughout his career, Richard Eric Olson has collaborated with leading research institutions, universities, and tech companies to further enhance his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Richard Eric Olson's remarkable journey as an inventor showcases his commitment to pushing the boundaries of technology and creating solutions that have a lasting impact on society. His innovative spirit continues to inspire future generations of inventors to think outside the box and pursue their creative visions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…